Cargando…
The pathological role of Wnt5a in psoriasis and psoriatic arthritis
Psoriasis (PsO) is a chronic inflammatory skin disease with both local and systemic components. PsO‐associated arthritis, known as psoriatic arthritis (PsA), develops in approximately 13%‐25% of PsO patients. Various factors associated with both PsO and PsA indicate that these conditions are part of...
Autores principales: | Tian, Faming, Mauro, Theodora M., Li, Zhengxiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714168/ https://www.ncbi.nlm.nih.gov/pubmed/31313518 http://dx.doi.org/10.1111/jcmm.14531 |
Ejemplares similares
-
Update on the treatment of psoriasis and psoriatic arthritis – role of apremilast
por: Forchhammer, Stephan, et al.
Publicado: (2015) -
Ustekinumab in the Treatment of Psoriasis and Psoriatic Arthritis
por: Savage, Laura J., et al.
Publicado: (2015) -
Cardiometabolic Comorbidities in Psoriasis and Psoriatic Arthritis
por: Puig, Lluís
Publicado: (2017) -
The role of epigenetics and immunological imbalance in the etiopathogenesis of psoriasis and psoriatic arthritis
por: Frischknecht, Lukas, et al.
Publicado: (2019) -
The Role of p38 MAPK in the Aetiopathogenesis of Psoriasis and Psoriatic Arthritis
por: Mavropoulos, Athanasios, et al.
Publicado: (2013)